ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 166 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $395,000 | +758.7% | 65,585 | +412.4% | 0.01% | +500.0% |
| Q3 2019 | $46,000 | -37.8% | 12,800 | -53.3% | 0.00% | 0.0% |
| Q2 2019 | $74,000 | -23.7% | 27,430 | +3.9% | 0.00% | -50.0% |
| Q3 2018 | $97,000 | +142.5% | 26,400 | +90.4% | 0.00% | +100.0% |
| Q4 2017 | $40,000 | -34.4% | 13,865 | +5.0% | 0.00% | 0.0% |
| Q2 2017 | $61,000 | -81.3% | 13,200 | -60.1% | 0.00% | -88.9% |
| Q1 2015 | $326,000 | – | 33,051 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |